Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesothelioma, Small Cell Lung Cancer, NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00325494
What this trial is testing

MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer

Who this might be right for
Pancreatic CancerMesotheliomaOvarian Cancer+1 more
Morphotek 24
Testing effectiveness (Phase 2)Study completedNCT03241173
What this trial is testing

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced Malignancies
Incyte Biosciences International Sàrl 52
Early research (Phase 1)Study completedNCT05538572
What this trial is testing

PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerGlioblastomaHead and Neck Squamous Cell Carcinoma+4 more
Prelude Therapeutics Incorporated 22
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Early research (Phase 1)Study completedNCT00020124
What this trial is testing

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT01139775
What this trial is testing

A Study in Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 76
Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Early research (Phase 1)Looking for participantsNCT03917043
What this trial is testing

APG-2449 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid CancerNon Small Cell Lung CancerEsophageal Cancer+2 more
Ascentage Pharma Group Inc. 165
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Testing effectiveness (Phase 2)Looking for participantsNCT06362369
What this trial is testing

Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Who this might be right for
Advanced CancerAdvanced Solid TumorMelanoma+15 more
7 Hills Pharma, LLC 126
Early research (Phase 1)Looking for participantsNCT05245500
What this trial is testing

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Who this might be right for
MesotheliomaNon Small Cell Lung CancerMalignant Peripheral Nerve Sheath Tumors+3 more
Bristol-Myers Squibb 336
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Testing effectiveness (Phase 2)WithdrawnNCT02661100
What this trial is testing

A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients

Who this might be right for
Non Small Cell Lung CancerAdvanced Triple Negative Breast CancerSmall Cell Lung Cancer+3 more
Case Comprehensive Cancer Center
Not applicableEnded earlyNCT02688166
What this trial is testing

Cardiac MRI Biomarker Testing (GCC 1618)

Who this might be right for
Breast CancerLung Cancer (Non-Small Cell)Thoracic Cancer+2 more
University of Maryland, Baltimore 6
Early research (Phase 1)Not Yet RecruitingNCT06652529
What this trial is testing

Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors (Phase 1)MesotheliomaColorectal Carcinoma+2 more
Aromics Therapeutics 35
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Not applicableLooking for participantsNCT05628376
What this trial is testing

TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO

Who this might be right for
Lung Cancer, Non-small CellSmall Cell Lung CancerPleural Mesothelioma
University College, London 600
Testing effectiveness (Phase 2)Ended earlyNCT02062632
What this trial is testing

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

Who this might be right for
Esophageal CarcinomaHypopharyngeal CarcinomaLaryngeal Carcinoma+11 more
Mayo Clinic 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03907852
What this trial is testing

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesothelioma, MalignantMesothelioma; Pleura+8 more
TCR2 Therapeutics 57
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06603987
What this trial is testing

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Who this might be right for
Thoracic Solid Malignant Tumor
Stella Pharma Corporation 30
Next Page